Anitha Rao MD, MA
@anitharf
Neurologist, Head of Analytics, Founder of @neurocern, Vice Chair Geriatric Neurology @AANmember, business council @forbes, @UCSF alumni, Views are my own.
ID: 2346217892
http://www.neurocern.com 16-02-2014 04:20:04
524 Tweet
1,1K Takipçi
999 Takip Edilen
Connecting #neurology and #insurance with real world outcomes. Who knew the lack of #neurologists would mean more patients would end up in nursing homes? We need more neurologists and neurology education @AANMember Neurology Today #neurotwitter Women in Neurology Women Neurologists Group
Join the Neurocern platform to access digital tools for easy EMR documentation, automated plans of care, and informatics to support neurological and cognitive patients Women Neurologists Group Dr. Neelum T. Aggarwal #MedTwitter #neurotwitter #NurseTwitter #Alzheimers #StrokeAwarenessMonth #dementia
What happens to patients with cognitive impairment who live in areas where there are a limited number of neurologists? @AANMember Women in Neurology Women's Brain Foundation Alzheimer's Association UsAgainstAlzheimer's World Young Leaders in Dementia Network World Dementia Council Urban Institute Mary E. Post, MBA, CAE UCSF MAC FamCaregiverAlliance Alzheimer's Drug Discovery Foundation
What's the difference between cognitive assessments and a neurological evaluation? See link below. @AANMember Women Neurologists Group Neurology Today Women in Neurology Women's Brain Foundation #neurotwitter #medtwitter
Looking forward to this insurtech event with @TheDIACommunity Reggy de Feniks Roger Peverelli Neurocern #Insurtech #healthcare #healthIT #predictiveanalytics #informatics #neuroinformatics #bigdata
Welcome you to the International Seminar on Artificial Intelligence and Data Science in Neurology Key note adress by Dr Anitha Rao Anitha Rao MD, MA You don't want to miss!! Register now. *For registration click on the below link* docs.google.com/.../1poY4_i8xB…...
On Aug 30, MATTER and Salt Flats will host experts from Rush University System for Health, Cognito Therapeutics and Neurocern to discuss the future of dementia and Alzheimer’s Disease care in the first of the #PatientExperience2040 series. Register today: bit.ly/3z70pr3